JavaScript NENÍ povolen !

Článek

FT
Medvik - BMČ

Je něco špatně v tomto záznamu ?

Conversion from clinically isolated syndrome to multiple sclerosis: A large multicentre study

J. Kuhle, G. Disanto, R. Dobson, R. Adiutori, L. Bianchi, J. Topping, JP. Bestwick, UC. Meier, M. Marta, G. Dalla Costa, T. Runia, E. Evdoshenko, N. Lazareva, E. Thouvenot, P. Iaffaldano, V. Direnzo, M. Khademi, F. Piehl, M. Comabella, M....

Multiple sclerosis. 2015 ; 21 (8) : 1013-24. [pub] 20150213

Mult Scler
ISSN 1477-0970
Medvik
Zdroj

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu časopisecké články, multicentrická studie, práce podpořená grantem

Perzistentní odkaz https://www.medvik.cz/link/bmc16020972

Online Plný text

NLK ProQuest Central od 1998-01-01 do 2015-12-31
SAGE Publications Journals od 1999-01-01 do 2015-12-31
Health & Medicine (ProQuest) od 1998-01-01 do 2015-12-31
Family Health Database (ProQuest) od 1998-01-01 do 2015-12-31

PubMed 25680984
DOI 10.1177/1352458514568827
Knihovny.cz E-zdroje

BACKGROUND AND OBJECTIVE: We explored which clinical and biochemical variables predict conversion from clinically isolated syndrome (CIS) to clinically definite multiple sclerosis (CDMS) in a large international cohort. METHODS: Thirty-three centres provided serum samples from 1047 CIS cases with at least two years' follow-up. Age, sex, clinical presentation, T2-hyperintense lesions, cerebrospinal fluid (CSF) oligoclonal bands (OCBs), CSF IgG index, CSF cell count, serum 25-hydroxyvitamin D3 (25-OH-D), cotinine and IgG titres against Epstein-Barr nuclear antigen 1 (EBNA-1) and cytomegalovirus were tested for association with risk of CDMS. RESULTS: At median follow-up of 4.31 years, 623 CIS cases converted to CDMS. Predictors of conversion in multivariable analyses were OCB (HR = 2.18, 95% CI = 1.71-2.77, p < 0.001), number of T2 lesions (two to nine lesions vs 0/1 lesions: HR = 1.97, 95% CI = 1.52-2.55, p < 0.001; >9 lesions vs 0/1 lesions: HR = 2.74, 95% CI = 2.04-3.68, p < 0.001) and age at CIS (HR per year inversely increase = 0.98, 95% CI = 0.98-0.99, p < 0.001). Lower 25-OH-D levels were associated with CDMS in univariable analysis, but this was attenuated in the multivariable model. OCB positivity was associated with higher EBNA-1 IgG titres. CONCLUSIONS: We validated MRI lesion load, OCB and age at CIS as the strongest independent predictors of conversion to CDMS in this multicentre setting. A role for vitamin D is suggested but requires further investigation.

Blizard Institute Queen Mary University of London Barts and The London School of Medicine and Dentistry UK

Blizard Institute Queen Mary University of London Barts and The London School of Medicine and Dentistry UK Departments of Neurology and Biomedicine University Hospital Basel University of Basel Switzerland

C Mondino National Neurological Institute Italy

Center for Neuroimmunology and Department of Neurology Institut d'investigacions Biomèdiques August Pi Sunyer Hospital Clinic of Barcelona Spain

Centre for Experimental Neurological Therapies S Andrea Hospital site Department of Neuroscience Mental Health and Sensory Organs Faculty of Medicine and Psychology Sapienza University Italy

Centre of Multiple Sclerosis City Clinical Hospital 31 Russia

Clinic of Neurology Belgrade University School of Medicine Serbia

Department of Basic Medical Sciences Neuroscience and Sense Organs University of Bari Italy

Department of Health Sciences and IRCAD Eastern Piedmont University Italy

Department of Neurology and Immunology Hospital Ramón y Cajal Spain

Department of Neurology and INSPE Vita Salute San Raffaele University Scientific Institute San Raffaele Italy

Department of Neurology Charles University Prague Czech Republic

Department of Neurology CSF Laboratory and MS Outpatient Unit University of Ulm Germany

Department of Neurology Erasmus MC University Medical Center The Netherlands

Department of Neurology Glostrup Hospital University of Copenhagen Denmark

Department of Neurology Innsbruck Medical University Austria

Department of Neurology Istanbul University Turkey

Department of Neurology Medical Faculty Heinrich Heine University Germany

Department of Neurology Medical University of Graz Austria

Department of Neurology Medical University of Lublin Poland

Department of Neurology of Hospital Británico of Buenos Aires Argentina

Department of Neurology Université de Lyon Université Claude Bernard Lyon 1 France

Department of Neurology University of Genoa Italy

Department of Neurology University of Szeged Hungary

Department of Neurology University of Toulouse France

Department of Physiology Anatomy and Genetics and Medical Research Council Functional Genomics Unit University of Oxford UK

Department of Radiology Innsbruck Medical University Austria

Departments of Neurology and Biomedicine University Hospital Basel University of Basel Switzerland

Departments of Neurology and Clinical Chemistry MS Center Neurocampus Amsterdam VU University Medical Centre Amsterdam The Netherlands and BioMS eu network

Dr Orhan Öcalgiray Molecular Biology Biotechnology and Genetics Research Centre Istanbul Technical University Turkey

Institut de Génomique Fonctionelle CNRS UMR5203 INSERM U661 Université Montpellier 1 Université Montpellier France and Hôpital Carémeau France

Institute of Neuroscience and Physiology The Sahlgrenska Academy University of Gothenburg Sweden

KG Jebsen Centre for MS Research Department of Clinical Medicine Haukeland University Hospital University of Bergen Norway

MS Centre SCDU Neurology Head and Neck Department AOU Maggiore della Carità Italy

MS Unit Neurology Department La Fe University and Polytechnic Hospital Instituto de investigación Sanitaria La Fe Spain

Neuroimmunology Unit Department of Clinical Neuroscience Karolinska Institutet Sweden

Neurology Unit Dept of Pathophysiology and Transplantation University of Milan Fondazione Cà Granda IRCCS Policlinico

Pôle de Neurosciences Cliniques Service de Neurologie Centre de Résonance Magnétique Biologique et Médicale Centre Hospitalier Universitaire Timone Laboratoire d'histocompatibilité Etablissement Français du Sang Alpes Méditerrannée Aix Marseille Université France

Servei de Neurologia Neuroimmunologia Centre d'Esclerosi Múltiple de Catalunya Hospital Universitari Vall d'Hebron Universitat Autònoma de Barcelona Spain

Unit of Functional Imaging Glostrup Hospital University of Copenhagen Denmark

Wolfson Institute of Preventive Medicine Queen Mary University of London Barts and the London School for Medicine and Dentistry UK

Citace poskytuje Crossref.org

000: 00000naa a2200000 a 4500

001: bmc16020972

003: CZ-PrNML

005: 20220524084502.0

007: ta

008: 160722s2015 enk f 000 0|eng||

009: AR

024 7_: $a 10.1177/1352458514568827 $2 doi

024 7_: $a 10.1177/1352458514568827 $2 doi

035 __: $a (PubMed)25680984

040 __: $a ABA008 $b cze $d ABA008 $e AACR2

041 0_: $a eng

044 __: $a enk

100 1_: $a Kuhle, J $u Blizard Institute, Queen Mary University of London, Barts and The London School of Medicine and Dentistry, UK/ Departments of Neurology and Biomedicine, University Hospital Basel, University of Basel, Switzerland.

245 10: $a Conversion from clinically isolated syndrome to multiple sclerosis: A large multicentre study / $c J. Kuhle, G. Disanto, R. Dobson, R. Adiutori, L. Bianchi, J. Topping, JP. Bestwick, UC. Meier, M. Marta, G. Dalla Costa, T. Runia, E. Evdoshenko, N. Lazareva, E. Thouvenot, P. Iaffaldano, V. Direnzo, M. Khademi, F. Piehl, M. Comabella, M. Sombekke, J. Killestein, H. Hegen, S. Rauch, S. D'Alfonso, JC. Alvarez-Cermeño, P. Kleinová, D. Horáková, R. Roesler, F. Lauda, S. Llufriu, T. Avsar, U. Uygunoglu, A. Altintas, S. Saip, T. Menge, C. Rajda, R. Bergamaschi, N. Moll, M. Khalil, R. Marignier, I. Dujmovic, H. Larsson, C. Malmestrom, E. Scarpini, C. Fenoglio, S. Wergeland, A. Laroni, V. Annibali, S. Romano, AD. Martínez, A. Carra, M. Salvetti, A. Uccelli, Ø. Torkildsen, KM. Myhr, D. Galimberti, K. Rejdak, J. Lycke, JL. Frederiksen, J. Drulovic, C. Confavreux, D. Brassat, C. Enzinger, S. Fuchs, I. Bosca, J. Pelletier, C. Picard, E. Colombo, D. Franciotta, T. Derfuss, R. Lindberg, Ö. Yaldizli, L. Vécsei, BC. Kieseier, HP. Hartung, P. Villoslada, A. Siva, A. Saiz, H. Tumani, E. Havrdová, LM. Villar, M. Leone, N. Barizzone, F. Deisenhammer, C. Teunissen, X. Montalban, M. Tintoré, T. Olsson, M. Trojano, S. Lehmann, G. Castelnovo, S. Lapin, R. Hintzen, L. Kappos, R. Furlan, V. Martinelli, G. Comi, SV. Ramagopalan, G. Giovannoni,

520 9_: $a BACKGROUND AND OBJECTIVE: We explored which clinical and biochemical variables predict conversion from clinically isolated syndrome (CIS) to clinically definite multiple sclerosis (CDMS) in a large international cohort. METHODS: Thirty-three centres provided serum samples from 1047 CIS cases with at least two years' follow-up. Age, sex, clinical presentation, T2-hyperintense lesions, cerebrospinal fluid (CSF) oligoclonal bands (OCBs), CSF IgG index, CSF cell count, serum 25-hydroxyvitamin D3 (25-OH-D), cotinine and IgG titres against Epstein-Barr nuclear antigen 1 (EBNA-1) and cytomegalovirus were tested for association with risk of CDMS. RESULTS: At median follow-up of 4.31 years, 623 CIS cases converted to CDMS. Predictors of conversion in multivariable analyses were OCB (HR = 2.18, 95% CI = 1.71-2.77, p < 0.001), number of T2 lesions (two to nine lesions vs 0/1 lesions: HR = 1.97, 95% CI = 1.52-2.55, p < 0.001; >9 lesions vs 0/1 lesions: HR = 2.74, 95% CI = 2.04-3.68, p < 0.001) and age at CIS (HR per year inversely increase = 0.98, 95% CI = 0.98-0.99, p < 0.001). Lower 25-OH-D levels were associated with CDMS in univariable analysis, but this was attenuated in the multivariable model. OCB positivity was associated with higher EBNA-1 IgG titres. CONCLUSIONS: We validated MRI lesion load, OCB and age at CIS as the strongest independent predictors of conversion to CDMS in this multicentre setting. A role for vitamin D is suggested but requires further investigation.

650 _2: $a dospělí $7 D000328

650 _2: $a kohortové studie $7 D015331

650 _2: $a progrese nemoci $7 D018450

650 _2: $a ženské pohlaví $7 D005260

650 _2: $a následné studie $7 D005500

650 _2: $a lidé $7 D006801

650 _2: $a imunoglobulin G $x analýza $7 D007074

650 _2: $a magnetická rezonanční tomografie $7 D008279

650 _2: $a mužské pohlaví $7 D008297

650 _2: $a roztroušená skleróza $x mok mozkomíšní $x patologie $7 D009103

650 _2: $a jaderné proteiny $x analýza $7 D009687

650 _2: $a oligoklonální proužky $x genetika $7 D043025

650 _2: $a prediktivní hodnota testů $7 D011237

650 _2: $a prognóza $7 D011379

650 _2: $a hodnocení rizik $7 D018570

650 _2: $a analýza přežití $7 D016019

650 _2: $a vitamin D $x krev $7 D014807

655 _2: $a časopisecké články $7 D016428

655 _2: $a multicentrická studie $7 D016448

655 _2: $a práce podpořená grantem $7 D013485

700 1_: $a Disanto, G $u Blizard Institute, Queen Mary University of London, Barts and The London School of Medicine and Dentistry, UK.

700 1_: $a Dobson, R $u Blizard Institute, Queen Mary University of London, Barts and The London School of Medicine and Dentistry, UK.

700 1_: $a Adiutori, R $u Blizard Institute, Queen Mary University of London, Barts and The London School of Medicine and Dentistry, UK. $7 gn_A_00001792

700 1_: $a Bianchi, L $u Blizard Institute, Queen Mary University of London, Barts and The London School of Medicine and Dentistry, UK.

700 1_: $a Topping, J $u Blizard Institute, Queen Mary University of London, Barts and The London School of Medicine and Dentistry, UK.

700 1_: $a Bestwick, J P $u Wolfson Institute of Preventive Medicine, Queen Mary University of London, Barts and the London School for Medicine and Dentistry, UK.

700 1_: $a Meier, U-C $u Blizard Institute, Queen Mary University of London, Barts and The London School of Medicine and Dentistry, UK.

700 1_: $a Marta, M $u Blizard Institute, Queen Mary University of London, Barts and The London School of Medicine and Dentistry, UK.

700 1_: $a Dalla Costa, G $u Department of Neurology and INSPE, Vita-Salute San Raffaele University, Scientific Institute San Raffaele, Italy.

700 1_: $a Runia, T $u Department of Neurology, Erasmus MC University Medical Center, The Netherlands.

700 1_: $a Evdoshenko, E $u Centre of Multiple Sclerosis, City Clinical Hospital#31, Russia.

700 1_: $a Lazareva, N $u Centre of Multiple Sclerosis, City Clinical Hospital#31, Russia.

700 1_: $a Thouvenot, E $u Institut de Génomique Fonctionelle, CNRS UMR5203, INSERM U661, Université Montpellier 1, Université Montpellier, France, and Hôpital Carémeau, France.

700 1_: $a Iaffaldano, P $u Department of Basic Medical Sciences, Neuroscience and Sense Organs, University of Bari, Italy.

700 1_: $a Direnzo, V $u Department of Basic Medical Sciences, Neuroscience and Sense Organs, University of Bari, Italy.

700 1_: $a Khademi, M $u Neuroimmunology Unit, Department of Clinical Neuroscience, Karolinska Institutet, Sweden.

700 1_: $a Piehl, F $u Neuroimmunology Unit, Department of Clinical Neuroscience, Karolinska Institutet, Sweden.

700 1_: $a Comabella, M $u Servei de Neurologia-Neuroimmunologia, Centre d'Esclerosi Múltiple de Catalunya (Cemcat), Institut de Receca Vall d'Hebron (VHIR), Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Spain.

700 1_: $a Sombekke, M $u Departments of Neurology and Clinical Chemistry, MS Center, Neurocampus Amsterdam, VU University Medical Centre Amsterdam, The Netherlands and BioMS-eu network.

700 1_: $a Killestein, J $u Departments of Neurology and Clinical Chemistry, MS Center, Neurocampus Amsterdam, VU University Medical Centre Amsterdam, The Netherlands and BioMS-eu network.

700 1_: $a Hegen, H $u Department of Neurology, Innsbruck Medical University, Austria.

700 1_: $a Rauch, S $u Department of Radiology, Innsbruck Medical University, Austria.

700 1_: $a D'Alfonso, S $u Department of Health Sciences and IRCAD, Eastern Piedmont University, Italy.

700 1_: $a Alvarez-Cermeño, J C $u Department of Neurology and Immunology, Hospital Ramón y Cajal, Spain. $7 gn_A_00005116

700 1_: $a Kleinová, Petra $u Department of Neurology, Charles University in Prague, Czech Republic. $7 xx0273120

700 1_: $a Horáková, D $u Department of Neurology, Charles University in Prague, Czech Republic.

700 1_: $a Roesler, R $u Department of Neurology, CSF Laboratory and MS Outpatient Unit, University of Ulm, Germany.

700 1_: $a Lauda, F $u Department of Neurology, CSF Laboratory and MS Outpatient Unit, University of Ulm, Germany.

700 1_: $a Llufriu, S $u Center for Neuroimmunology and Department of Neurology. Institut d'investigacions Biomèdiques August Pi Sunyer (IDIBAPS) - Hospital Clinic of Barcelona, Spain.

700 1_: $a Avsar, T $u Dr Orhan Öcalgiray Molecular Biology-Biotechnology and Genetics Research Centre, Istanbul Technical University, Turkey. $7 gn_A_00010434

700 1_: $a Uygunoglu, U $u Department of Neurology, Istanbul University, Turkey.

700 1_: $a Altintas, A $u Department of Neurology, Istanbul University, Turkey. $7 gn_A_00004964

700 1_: $a Saip, S $u Department of Neurology, Istanbul University, Turkey.

700 1_: $a Menge, T $u Department of Neurology, Medical Faculty, Heinrich-Heine-University, Germany.

700 1_: $a Rajda, C $u Department of Neurology, University of Szeged, Hungary.

700 1_: $a Bergamaschi, R $u C. Mondino National Neurological Institute, Italy.

700 1_: $a Moll, N $u Pôle de Neurosciences Cliniques, Service de Neurologie, Centre de Résonance Magnétique Biologique et Médicale, Centre Hospitalier Universitaire Timone, Laboratoire d'histocompatibilité, Etablissement Français du Sang Alpes Méditerrannée, Aix Marseille Université, France.

700 1_: $a Khalil, M $u Department of Neurology, Medical University of Graz, Austria.

700 1_: $a Marignier, R $u Department of Neurology, Université de Lyon, Université Claude Bernard-Lyon 1, France.

700 1_: $a Dujmovic, I $u Clinic of Neurology, Belgrade University School of Medicine, Serbia.

700 1_: $a Larsson, H $u Unit of Functional Imaging, Glostrup Hospital, University of Copenhagen, Denmark.

700 1_: $a Malmestrom, C $u Institute of Neuroscience and Physiology, The Sahlgrenska Academy, University of Gothenburg, Sweden.

700 1_: $a Scarpini, E $u Neurology Unit, Dept. of Pathophysiology and Transplantation, University of Milan, Fondazione Cà Granda, IRCCS Policlinico.

700 1_: $a Fenoglio, C $u Neurology Unit, Dept. of Pathophysiology and Transplantation, University of Milan, Fondazione Cà Granda, IRCCS Policlinico.

700 1_: $a Wergeland, S $u KG Jebsen Centre for MS-Research, Department of Clinical Medicine, Haukeland University Hospital, University of Bergen, Norway.

700 1_: $a Laroni, A $u Department of Neurology, University of Genoa, Italy.

700 1_: $a Annibali, V $u Centre for Experimental Neurological Therapies, S. Andrea Hospital-site, Department of Neuroscience, Mental Health and Sensory Organs (NESMOS), Faculty of Medicine and Psychology, Sapienza University, Italy. $7 gn_A_00007140

700 1_: $a Romano, S $u Centre for Experimental Neurological Therapies, S. Andrea Hospital-site, Department of Neuroscience, Mental Health and Sensory Organs (NESMOS), Faculty of Medicine and Psychology, Sapienza University, Italy.

700 1_: $a Martínez, A D $u Department of Neurology of Hospital Británico of Buenos Aires, Argentina.

700 1_: $a Carra, A $u Department of Neurology of Hospital Británico of Buenos Aires, Argentina.

700 1_: $a Salvetti, M $u Centre for Experimental Neurological Therapies, S. Andrea Hospital-site, Department of Neuroscience, Mental Health and Sensory Organs (NESMOS), Faculty of Medicine and Psychology, Sapienza University, Italy.

700 1_: $a Uccelli, A $u Department of Neurology, University of Genoa, Italy.

700 1_: $a Torkildsen, Ø $u KG Jebsen Centre for MS-Research, Department of Clinical Medicine, Haukeland University Hospital, University of Bergen, Norway.

700 1_: $a Myhr, K M $u Department of Neurology, University of Genoa, Italy.

700 1_: $a Galimberti, D $u Neurology Unit, Dept. of Pathophysiology and Transplantation, University of Milan, Fondazione Cà Granda, IRCCS Policlinico.

700 1_: $a Rejdak, K $u Department of Neurology, Medical University of Lublin, Poland.

700 1_: $a Lycke, J $u Institute of Neuroscience and Physiology, The Sahlgrenska Academy, University of Gothenburg, Sweden.

700 1_: $a Frederiksen, J L $u Department of Neurology, Glostrup Hospital, University of Copenhagen, Denmark.

700 1_: $a Drulovic, J $u Clinic of Neurology, Belgrade University School of Medicine, Serbia.

700 1_: $a Confavreux, C $u Department of Neurology, Université de Lyon, Université Claude Bernard-Lyon 1, France.

700 1_: $a Brassat, D $u Department of Neurology, University of Toulouse, France.

700 1_: $a Enzinger, C $u Department of Neurology, Medical University of Graz, Austria.

700 1_: $a Fuchs, S $u Department of Neurology, Medical University of Graz, Austria.

700 1_: $a Bosca, I $u MS Unit, Neurology Department, La Fe University and Polytechnic Hospital, Instituto de investigación Sanitaria La Fe, Spain.

700 1_: $a Pelletier, J $u Pôle de Neurosciences Cliniques, Service de Neurologie, Centre de Résonance Magnétique Biologique et Médicale, Centre Hospitalier Universitaire Timone, Laboratoire d'histocompatibilité, Etablissement Français du Sang Alpes Méditerrannée, Aix Marseille Université, France.

700 1_: $a Picard, C $u Pôle de Neurosciences Cliniques, Service de Neurologie, Centre de Résonance Magnétique Biologique et Médicale, Centre Hospitalier Universitaire Timone, Laboratoire d'histocompatibilité, Etablissement Français du Sang Alpes Méditerrannée, Aix Marseille Université, France.

700 1_: $a Colombo, E $u C. Mondino National Neurological Institute, Italy.

700 1_: $a Franciotta, D $u C. Mondino National Neurological Institute, Italy.

700 1_: $a Derfuss, T $u Departments of Neurology and Biomedicine, University Hospital Basel, University of Basel, Switzerland.

700 1_: $a Lindberg, Rlp $u Departments of Neurology and Biomedicine, University Hospital Basel, University of Basel, Switzerland.

700 1_: $a Yaldizli, Ö $u Departments of Neurology and Biomedicine, University Hospital Basel, University of Basel, Switzerland.

700 1_: $a Vécsei, L $u Department of Neurology, University of Szeged, Hungary.

700 1_: $a Kieseier, B C $u Department of Neurology, Medical Faculty, Heinrich-Heine-University, Germany.

700 1_: $a Hartung, H P $u Department of Neurology, Medical Faculty, Heinrich-Heine-University, Germany.

700 1_: $a Villoslada, P $u Center for Neuroimmunology and Department of Neurology. Institut d'investigacions Biomèdiques August Pi Sunyer (IDIBAPS) - Hospital Clinic of Barcelona, Spain.

700 1_: $a Siva, A $u Department of Neurology, Istanbul University, Turkey.

700 1_: $a Saiz, A $u Center for Neuroimmunology and Department of Neurology. Institut d'investigacions Biomèdiques August Pi Sunyer (IDIBAPS) - Hospital Clinic of Barcelona, Spain.

700 1_: $a Tumani, H $u Department of Neurology, CSF Laboratory and MS Outpatient Unit, University of Ulm, Germany.

700 1_: $a Havrdová, E $u Department of Neurology, Charles University in Prague, Czech Republic.

700 1_: $a Villar, L M $u Department of Neurology and Immunology, Hospital Ramón y Cajal, Spain.

700 1_: $a Leone, M $u MS Centre, SCDU Neurology, Head and Neck Department, AOU Maggiore della Carità, Italy.

700 1_: $a Barizzone, N $u Department of Health Sciences and IRCAD, Eastern Piedmont University, Italy.

700 1_: $a Deisenhammer, F $u Department of Neurology, Innsbruck Medical University, Austria.

700 1_: $a Teunissen, C $u Departments of Neurology and Clinical Chemistry, MS Center, Neurocampus Amsterdam, VU University Medical Centre Amsterdam, The Netherlands and BioMS-eu network.

700 1_: $a Montalban, X $u Servei de Neurologia-Neuroimmunologia, Centre d'Esclerosi Múltiple de Catalunya (Cemcat), Institut de Receca Vall d'Hebron (VHIR), Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Spain.

700 1_: $a Tintoré, M $u Servei de Neurologia-Neuroimmunologia, Centre d'Esclerosi Múltiple de Catalunya (Cemcat), Institut de Receca Vall d'Hebron (VHIR), Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Spain.

700 1_: $a Olsson, T $u Neuroimmunology Unit, Department of Clinical Neuroscience, Karolinska Institutet, Sweden.

700 1_: $a Trojano, M $u Department of Basic Medical Sciences, Neuroscience and Sense Organs, University of Bari, Italy.

700 1_: $a Lehmann, S $u Institut de Génomique Fonctionelle, CNRS UMR5203, INSERM U661, Université Montpellier 1, Université Montpellier, France, and Hôpital Carémeau, France.

700 1_: $a Castelnovo, G $u Institut de Génomique Fonctionelle, CNRS UMR5203, INSERM U661, Université Montpellier 1, Université Montpellier, France, and Hôpital Carémeau, France.

700 1_: $a Lapin, S $u Centre of Multiple Sclerosis, City Clinical Hospital#31, Russia.

700 1_: $a Hintzen, R $u Department of Neurology, Erasmus MC University Medical Center, The Netherlands.

700 1_: $a Kappos, L $u Departments of Neurology and Biomedicine, University Hospital Basel, University of Basel, Switzerland.

700 1_: $a Furlan, R $u Department of Neurology and INSPE, Vita-Salute San Raffaele University, Scientific Institute San Raffaele, Italy.

700 1_: $a Martinelli, V $u Department of Neurology and INSPE, Vita-Salute San Raffaele University, Scientific Institute San Raffaele, Italy.

700 1_: $a Comi, G $u Department of Neurology and INSPE, Vita-Salute San Raffaele University, Scientific Institute San Raffaele, Italy.

700 1_: $a Ramagopalan, S V $u Department of Physiology, Anatomy and Genetics and Medical Research Council Functional Genomics Unit, University of Oxford, UK.

700 1_: $a Giovannoni, G $u Blizard Institute, Queen Mary University of London, Barts and The London School of Medicine and Dentistry, UK g.giovannoni@qmul.ac.uk.

773 0_: $w MED00006389 $t Multiple sclerosis (Houndmills, Basingstoke, England) $x 1477-0970 $g Roč. 21, č. 8 (2015), s. 1013-24

856 41: $u https://pubmed.ncbi.nlm.nih.gov/25680984 $y Pubmed

910 __: $a ABA008 $b sig $c sign $y a $z 0

990 __: $a 20160722 $b ABA008

991 __: $a 20220524084459 $b ABA008

999 __: $a ok $b bmc $g 1155642 $s 945500

BAS __: $a 3

BAS __: $a PreBMC

BMC __: $a 2015 $b 21 $c 8 $d 1013-24 $e 20150213 $i 1477-0970 $m Multiple sclerosis $n Mult Scler $x MED00006389

LZP __: $a Pubmed-20160722

Zpět

Najít záznam

v PubMed

Conversion from clinically isolated syndrome to multiple sclerosis: A large multicentre study

Najít záznam

Citační ukazatele

Možnosti archivace